Memorial Sloan Kettering Cancer Center: Dr. Katharine Hsu Named Director of Tri-Institutional M.D.-Ph.D. Program
April 10, 2021
April 10, 2021
NEW YORK, April 10 (TNSPer) -- The Memorial Sloan Kettering Cancer Center issued the following news release:
Dr. Katharine Hsu, an esteemed physician-scientist who specializes in immunology research and treatment of blood cancers, has been named director of the Tri-Institutional M.D.-Ph.D. Program, a joint program between Weill Cornell Medicine, The Rockefeller University and Memorial Sloan Kettering Cancer Center.
Founded in 1972, the Tri-Institutional M.D.-Ph.D. Progr . . .
Dr. Katharine Hsu, an esteemed physician-scientist who specializes in immunology research and treatment of blood cancers, has been named director of the Tri-Institutional M.D.-Ph.D. Program, a joint program between Weill Cornell Medicine, The Rockefeller University and Memorial Sloan Kettering Cancer Center.
Founded in 1972, the Tri-Institutional M.D.-Ph.D. Progr . . .